Synthesis, molecular docking and CNS activity of 5,5-diphenylimidazolidine-2,4-dione derivatives.

The new Phenytoin derivatives have been synthesized, characterized, and compared for CNS activity. The synthesis was carried out in three steps. Firstly, the chloroacetylation of the 5,5-diphenyl hydantoin is carried out and then various substituted phenols are added into it and have been evaluated for anti-anxiety activity, muscle relaxant activity and anticonvulsant activity by using different models. The number of parameters have been optimized which reveal that the compound containing chloro group such as C3 and C6 show imperative potential when compared with the standard drug Diazepam. The newly synthesised compounds have the probability to be optimized further to engender new scaffolds to treat various CNS disorders. [ABSTRACT FROM AUTHOR]